Open AccessCOVID‐19 in a human T‐cell lymphotropic virus type‐1 carrier
Author(s) -
Enomoto Takatoshi,
Shiroyama Takayuki,
Hirata Haruhiko,
Amiya Saori,
Adachi Yuichi,
Niitsu Takayuki,
Noda Yoshimi,
Hara Reina,
Fukushima Kiyoharu,
Suga Yasuhiko,
Miyake Kotaro,
Koyama Shohei,
Iwahori Kota,
Nagatomo Izumi,
Tokuhira Natsuko,
Uchiyama Akinori,
Takeda Yoshito,
Kumanogoh Atsushi
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5463
Subject(s) - medicine , covid-19 , virology , disease , outbreak , infectious disease (medical specialty)
This is the first report of COVID‐19 in a human T‐cell lymphotropic virus type‐1 (HTLV‐1) carrier. HTLV‐1 infection can cause immune dysfunction even in asymptomatic carriers. This case highlights the need for guidance on management of COVID‐19‐HTLV‐1 coinfection, specifically on the appropriate use of corticosteroid treatment while considering secondary infection.